Trader consensus on Polymarket reflects a 92.4% implied probability against a new coronavirus pandemic in 2026, driven by stable global COVID-19 epidemiology with declining or low confirmed cases per CDC and WHO surveillance as of late March 2026. Widespread population immunity from prior SARS-CoV-2 infections and vaccinations has curtailed transmission dynamics, reducing vulnerability to novel coronaviruses, as evidenced by University of Glasgow research. The emerging BA.3.2 "Cicada" variant, detected in 25 U.S. states and low-prevalence globally (<0.2% of sequences), shows no signs of exponential growth or severe outcomes warranting WHO public health emergency status. Key upcoming CDC variant tracking and WHO dashboards could shift sentiment if immune-escape mutations trigger multi-country outbreaks exceeding historical pandemic thresholds.